Hemoperitoneum in a dog with cranial mediastinal lymphoma.
1/5 보강
A 2-year-old neutered male terrier-mix dog was presented to a multispecialty hospital because of acute onset of lethargy and a single episode of vomiting.
APA
Gonzalez A, Walton R, Bajorek S (2026). Hemoperitoneum in a dog with cranial mediastinal lymphoma.. The Canadian veterinary journal = La revue veterinaire canadienne, 67(1), 21-25.
MLA
Gonzalez A, et al.. "Hemoperitoneum in a dog with cranial mediastinal lymphoma.." The Canadian veterinary journal = La revue veterinaire canadienne, vol. 67, no. 1, 2026, pp. 21-25.
PMID
41586140 ↗
Abstract 한글 요약
A 2-year-old neutered male terrier-mix dog was presented to a multispecialty hospital because of acute onset of lethargy and a single episode of vomiting. The dog was unstable on admission and had a moderate hemoperitoneum as determined by point-of-care ultrasonography. Additional diagnostic tests revealed a cranial mediastinal mass and scant pleural effusion. After the dog was stabilized, a computed tomographic scan confirmed a cranial mediastinal mass with bicavitary effusion as well as bicavitary lymphadenopathy. Cytologic examination of thoracic fluid was most consistent with intermediate- to large-cell lymphoma. The dog was treated with a single glucocorticoid injection, a single administration of L-asparaginase, and oral glucocorticoid therapy that was tapered to discontinuation. The dog was presented deceased on arrival at 38 d after the initial presentation to the specialty hospital. This case report describes an uncommon differential diagnosis to consider in cases of hemoperitoneum. Key clinical message: Hemoperitoneum may occur secondary to non-intra-abdominal disease, such as mediastinal lymphoma, and a complete systemic workup should be completed.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (1)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- SpNeigh: spatial neighborhood and differential expression analysis for high-resolution spatial transcriptomics.
- Key Considerations for Targeting in Pancreatic Cancer: Potential Impact on the Treatment Paradigm.
- The tumor microenvironment as a key regulator of radiotherapy response.
- Overcoming Chemoresistance in Glioblastoma: Mechanisms, Therapeutic Strategies, and Functional Precision Medicine.
- Advances in green-synthesized magnetic nanoparticles for targeted cancer therapy: mechanisms, applications, and future perspectives.
- SMURF2 in Anticancer Therapy: Dual Role in Carcinogenesis and Theranostics.